May 27, 2016
Recommended Topic Related To:

Kogenate FS

"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.

Po"...

A A A

Kogenate FS




Overdosage
Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

Kogenate FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 4/4/2014

Overdosage
Contraindications

Kogenate FS - User Reviews

Kogenate FS User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Kogenate FS sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.